Yarrow Bioscience (YARW) Current Deferred Revenue (2016 - 2018)
Yarrow Bioscience's (YARW) quarterly Current Deferred Revenue came in at $1.8 million in Q1 2018, little changed on a QoQ basis from $1.8 million in Q4 2017.
Yarrow Bioscience (YARW) Current Deferred Revenue (2016 - 2018) Analysis & Trends
Yarrow Bioscience (YARW) has 3 years of Current Deferred Revenue data on file, last reported at $1.8 million in Q1 2018.
- Quarterly Current Deferred Revenue changed N/A year-over-year to $1.8 million in Q1 2018, while the trailing twelve-month figure through Mar 2018 was $1.8 million (changed N/A YoY) and the FY2017 annual result came in at $1.8 million, changed 0.0% from the prior year.
- Current Deferred Revenue held at $1.8 million in Q1 2018, from $1.8 million in the prior quarter.
- In the past five years, Current Deferred Revenue ranged from a high of $1.8 million in Q4 2016 to a low of $1.8 million in Q4 2016.
- A 3-year average of $1.8 million and a median of $1.8 million in 2016 frame the typical range for Current Deferred Revenue.
- The widest YoY moves for Current Deferred Revenue: up 0.0% in 2017, down 0.0% in 2017.
- Tracing YARW's Current Deferred Revenue over 3 years: stood at $1.8 million in 2016, then changed by 0.0% to $1.8 million in 2017, then changed by 0.0% to $1.8 million in 2018.
- The last three Current Deferred Revenue figures came in at $1.8 million (Q1 2018), $1.8 million (Q4 2017), and $1.8 million (Q4 2016), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Yarrow Bioscience | 31.25 Mn | 8.33 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2018 | 1.80 Mn |
| Dec 31, 2017 | 1.80 Mn |
| Dec 31, 2016 | 1.80 Mn |